Skip to main content
Logo
European Innovation Council
  • private sector

NETRIS PHARMA SAS

Driving superior clinical benefits for patients in the treatment of cancer

netris pharma

Overview

Description

Operator of a biopharmaceutical company intended to drive superior clinical benefits for patients in the treatment of cancer. The company's therapies work by targeting the dependence receptors to effectively restore the dependence receptor apoptosis signaling pathway in the absence of the required stimulus, enabling physicians and doctors to effectively cure cancers.

Website
Country
  • France
Sector
  • Health Biotechnology